Health News Archive - February 12, 2010

The tiny tongue of a fruit fly could provide big answers to questions about human eating habits, possibly even leading to new ways to treat obesity.

Rice grad student's technique helps scanners pinpoint tumors.

NEW YORK, Feb. 12 /PRNewswire-Asia-FirstCall/ -- NeoStem, Inc. (NYSE Amex: NBS) ("NeoStem" or the "Company"), an international biopharmaceutical company with operations in the U.S.

OXFORD, England, February 12 /PRNewswire/ -- Circassia Ltd, a specialty biopharmaceutical company focused on allergy, today announced that its ToleroMune(R) ragweed allergy T-cell vaccine achieved positive results in a recently completed phase II clinical trial.

SHENZHEN, China, Feb.

BRISBANE, Calif., Feb. 12 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: ITMN) announced today that it will release fourth quarter and full year 2009 financial results on Wednesday, February 17, 2010 at 4:00 p.m. Eastern time.

SAN DIEGO, Feb. 12 /PRNewswire/ -- Euthymics Bioscience, Inc., a privately held Delaware corporation, today announced that it has signed a non-binding Letter of Intent (LOI) to merge into and acquire DOV Pharmaceutical, Inc.

SEATTLE, Feb. 12 /PRNewswire-FirstCall/ -- Pacific Biomarkers, Inc. (OTC Bulletin Board: PBME), a leading provider of specialized biomarker and contract research services, today announced its operating results for the second quarter and first half of FY2010.

COLUMBIA, Md., Feb.

LEWISBERRY, Pa., Feb.